“Effect of Upadacitinib on Biomarkers of Systemic Inflammation in Patients With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s742, https://doi.org/10.25251/y5v7d428.